Your session is about to expire
← Back to Search
Donepezil for Memory Loss after Traumatic Brain Injury (MEMRI-TBI-D Trial)
MEMRI-TBI-D Trial Summary
This trial will test whether donepezil improves verbal memory in people with TBI.
MEMRI-TBI-D Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMEMRI-TBI-D Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MEMRI-TBI-D Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the research landscape surrounding Donepezil?
"There are a total of 16 ongoing clinical trials investigating Donepezil. 3 of those live trials are currently in Phase 3 testing. Many of the trials for Donepezil are based in Hallandale Beach, Florida, but there are 31 research locations running these tests across the United States."
Will this research be conducted with elderly participants?
"According to the inclusion criteria for this study, patients aged 18 to 60 are eligible to apply. There are 72 studies currently being conducted involving patients under 18 and 291 studies being done with elderly patients."
Are we still recruiting participants for this experiment?
"As of now, this trial is not looking for any more participants. According to the clinicaltrial.gov website, the last edit was on September 20th, 2022. If you are interested in other studies, there are currently 371 trials actively recruiting patients with memory disturbances and 16 trials for Donepezil that have open enrollment."
How can I become a test subject for this research?
"This trial is designed for 160 patients that are experiencing memory issues and fall in the age range of 18 to 60 years old."
Why is Donepezil commonly given to patients?
"Donepezil is frequently used to help patients with alzheimer's disease, but it can also be useful for those struggling with mild dementia of the Alzheimer's type, vascular dementia, and general dementia."
What is the FDA's official opinion on Donepezil?
"There is both animal and human data supporting Donepezil's safety, so it received a score of 3."
In how many different medical clinics is this research project being conducted today?
"There are 4 sites for this clinical trial, all of which are listed below. It is essential that patients select the clinic nearest to them in order to reduce travel-related burdens. -Charlestown -Elkins Park -Houston"
How many test subjects are enrolled in this experiment?
"As of September 20th, 2022, this trial is no longer seeking patients. It was initially posted on October 1st, 2013. If you are interested in other studies, 371 trials for memory disturbances and 16 for Donepezil are still looking for participants."
Does this trial break new ground in the medical field?
"Since 2013, when the first trial for Donepezil was completed, there has been significant global interest in this medication. Dong-A Pharmaceutical Co., Ltd. sponsored the original study which had 210 participants. After successful completion of Phase 3 trials, today there are 16 active clinical trials being conducted across 7 countries and 21 cities."
Share this study with friends
Copy Link
Messenger